AdvanCell Thorium-228 Manufacturing Capability
Sector: Government • Location: Queensland, Australia
Source: OpenGov Asia
Establishment of Australia's first sovereign manufacturing capability for Thorium-228, a key isotope used in targeted alpha therapies for cancer treatment. The project aims to position Queensland as a global leader in commercial-scale production of Thorium-228 and create 79 new jobs.
- Status
- Prospective
- Sector
- Government, Manufacturing (Industrial), Commercial
- Location
- Queensland, Australia
- Updated
- 22 Jul 2026
- Source
- OpenGov Asia
ConstructChat
Ask ConstructChat about AdvanCell Thorium-228 Manufacturing Capability
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Establishment of Australia's first sovereign manufacturing capability for Thorium-228, a key isotope used in targeted alpha therapies for cancer treatment. The project aims to position Queensland as a global leader in commercial-scale production of Thorium-228 and create 79 new jobs. |
Original sector | HealthTech |
Budget |
Location
Country | Australia |
State | Queensland |
Source
Source | OpenGov Asia |
URL |
More Details
Record type | Project |
Sector | Government, Manufacturing (Industrial), Commercial |
Article published date | 2026-05-11 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project